Clinical Trial Update: Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating valproic acid for Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) has completed. The study was sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1-associated Myelopathy
• Tropical Spastic Paraparesis

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University of Sao Paulo | Conditions: Paraparesis Spastic Tropical | Phase 3 | Status: COMPLETED